Anthrax LF Polyclonal Antibody is a crucial tool in the study of Bacillus anthracis, the bacterium responsible for anthrax. This antibody specifically targets the lethal factor (LF) component of the anthrax toxin, which is one of the three proteins produced by B. anthracis, alongside protective antigen (PA) and edema factor (EF).
The anthrax toxin is a tripartite protein complex consisting of:
The process begins with PA binding to its cell-surface receptor, known as the anthrax toxin receptor (ATR). Once bound, PA is cleaved by a furin-like protease, resulting in a fragment that can bind both LF and EF. This complex is then endocytosed, allowing LF and EF to translocate into the cytoplasm of the host cell. LF, in particular, cleaves members of the mitogen-activated protein kinase kinase (MAPKK) family, disrupting cellular signaling and leading to cell death .
This polyclonal antibody is widely used in various research applications, including: